(Q38597236)

4 September 2017

title

The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells (English)

1 reference

4 September 2017

Quentin Bazot

2

0 references

Robert E White

object named as

Robert E White

series ordinal

3

0 references

Martin J Allday

series ordinal

1

object named as

Martin J Allday

1 reference

4 September 2017

publication date

1 January 2015

1 reference

Current Topics in Microbiology and Immunology

4 September 2017

published in

1 reference

4 September 2017

volume

391

1 reference

4 September 2017

page(s)

61-117

1 reference

Senescence: a new weapon for cancer therapy

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBV persistence in memory B cells in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Default repression and Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho and dCtBP to Suppressor of Hairless

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

DNA damage signalling guards against activated oncogenes and tumour progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The spatial organization of the human genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Genome architecture: domain organization of interphase chromosomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Oncogene-Induced Senescence: Putting the Brakes on Tumor Development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3A contains six nuclear-localization signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Nuclear localization of the Epstein-Barr virus EBNA3B protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus and virus human protein interaction maps

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epigenetic inheritance: histone bookmarks across generations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Linking DNA methylation and histone modification: patterns and paradigms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Transcriptional regulation by C-terminal binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Biology and disease associations of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The great MYC escape in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Bim is a suppressor of Myc-induced mouse B cell leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Novel simian homologues of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

31 March 2020

Historical background

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus genetics: talking about the BAC generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA3C interacts with Gadd34 and counteracts the unfolded protein response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The Notch signalling system: recent insights into the complexity of a conserved pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

An oncogene-induced DNA damage model for cancer development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus U leader exon contains an internal ribosome entry site

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Identification of the nuclear localization signals within the Epstein-Barr virus EBNA-6 protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Intrinsic tumour suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Novel intertypic recombinants of epstein-barr virus in the chinese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Transcriptional repression by suppressor of hairless involves the binding of a hairless-dCtBP complex in Drosophila.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Soluble factors produced by activated CD4+ T cells modulate EBV latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Analysis of long-range chromatin interactions using Chromosome Conformation Capture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Targeting Epstein-Barr virus-associated lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The DNA damage response in viral-induced cellular transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA3C coactivation with EBNA2 requires a SUMO homology domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The intersection of Epstein-Barr virus with the germinal center

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Ink4-Arf locus in cancer and aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Coordinated histone modifications mediated by a CtBP co-repressor complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBV transformation overrides gene expression patterns of B cell differentiation stages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The role of BH3-only proteins in the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The carboxy-terminal region of adenovirus E1A activates transcription through targeting of a C-terminal binding protein-histone deacetylase complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epigenetic regulation of EBV persistence and oncogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The curious case of the tumour virus: 50 years of Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The pathogenesis of Epstein-Barr virus persistent infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Heterogeneous Epstein-Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Lymphomas differ in their dependence on Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Blinded by the Light: The Growing Complexity of p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Structure and function of the Epstein-Barr virus transcription factor, EBNA 3C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Comparative analysis of the Epstein-Barr virus encoded nuclear proteins of EBNA-3 family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus: 40 years on

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Redox sensor CtBP mediates hypoxia-induced tumor cell migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Transcriptional Regulatory Properties of Epstein-Barr Virus Nuclear Antigen 3C Are Conserved in Simian Lymphocryptoviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_3

10.1007/978-3-319-22834-1_3

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference